“Management Of Metabolic Effects Associated With Anticancer Agents Targeting The Pi3K-Akt-Mtor Pathway.”. J Clin Oncol 30 (23). J Clin Oncol: 2919-28. doi:10.1200/JCO.2011.39.7356.
. 2012. “The Current Understanding Of The Endocrine Effects From Immune Checkpoint Inhibitors And Recommendations For Management.”. Jnci Cancer Spectr 2 (3). Jnci Cancer Spectr: pky021. doi:10.1093/jncics/pky021.
. 2018.